ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IMM Immupharma Plc

2.18
-0.205 (-8.60%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.205 -8.60% 2.18 2.10 2.26 2.21 2.18 2.21 759,115 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.93 7.33M

Immupharma PLC Holding(s) in Company (4207Q)

29/02/2016 8:02am

UK Regulatory


TIDMIMM

RNS Number : 4207Q

Immupharma PLC

29 February 2016

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
--------------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                               Immupharma plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: 
----------------------------------------------------------  --------------------------------------------- 
 2. Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                                        x 
----------------------------------------------------------------------------------------------  --------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
----------------------------------------------------------------------------------------------  --------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
----------------------------------------------------------------------------------------------  --------- 
 An event changing the breakdown of voting rights 
----------------------------------------------------------------------------------------------  --------- 
 Other (please 
  specify): 
---------------------  -----------------------------------------------------------------------  --------- 
 3. Full name of person(s)                                Lanstead Capital LP 
  subject to the 
  notification obligation: 
--------------------------------------------  ----------------------------------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.): 
--------------------------------------------  ----------------------------------------------------------- 
 5. Date of the transaction                               25 February 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: 
--------------------------------------------  ----------------------------------------------------------- 
 6. Date on which issuer                                  26 February 2016 
  notified: 
--------------------------------------------  ----------------------------------------------------------- 
 7. Threshold(s) that is/are 
  crossed or                                              3%, 4%, 5%, 6%, 7%, 8%, 9%, 
  reached:                                                 10%, 11%, 12%, 13%, 14%, 15% 
--------------------------------------------  ----------------------------------------------------------- 
 8. Notified details: 
--------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares 
--------------------------------------------------------------------------------------------------------- 
 Class/type             Situation previous     Resulting situation after the 
  of                     to the triggering      triggering transaction 
  shares                 transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
---------------------  ---------------------  ----------------------------------------------------------- 
                        Number    Number       Number        Number of               % of voting 
                        of         of          of shares      voting                  rights 
                        Shares     Voting                     rights 
                                   Rights 
---------------------  --------  -----------  ------------  ----------------------  --------------------- 
                                               Direct        Direct       Indirect   Direct      Indirect 
---------------------  --------  -----------  ------------  -----------  ---------  ----------  --------- 
 GB0033711010           0         0            17,872,341    17,872,341              15.03% 
---------------------  --------  -----------  ------------  -----------  ---------  ----------  --------- 
 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial         Expiration     Exercise/                          Number of voting       % of voting 
  instrument                date           Conversion                         rights that            rights 
                                           Period                             may be 
                                                                              acquired if 
                                                                              the 
                                                                              instrument 
                                                                              is 
                                                                              exercised/ 
                                                                              converted. 
------------------------  -------------  ---------------------------------  ---------------------  ------------------- 
           N/A 
------------------------  -------------  ---------------------------------  ---------------------  ------------------- 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial       Exercise       Expiration     Exercise/           Number of voting       % of voting 
  instrument             price          date            Conversion         rights instrument       rights 
                                                        period             refers to 
----------------------  -------------  -------------  ------------------  ---------------------  --------------------- 
          N/A                                                                                     Nominal     Delta 
----------------------  -------------  -------------  ------------------  ---------------------  ----------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                                   Percentage of voting rights 
------------------------------------------------------------------------  -------------------------------------------- 
 17,872,341                                                                15.03% 
------------------------------------------------------------------------  -------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
---------------------------------------------------------------------------------------- 
 N/A 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  ------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  ------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  ------------------------- 
 
 13. Additional information: 
-------------------------------------------------------------  ------------------------- 
 14. Contact name:                                              Lisa De Vargas, Lanstead 
                                                                Partners Limited 
-------------------------------------------------------------  ------------------------- 
 15. Contact telephone number:                                  +1 (801) 895-3700 
-------------------------------------------------------------  ------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLDKLBLQLFEBBK

(END) Dow Jones Newswires

February 29, 2016 03:02 ET (08:02 GMT)

1 Year Immupharma Chart

1 Year Immupharma Chart

1 Month Immupharma Chart

1 Month Immupharma Chart

Your Recent History

Delayed Upgrade Clock